Harmony Biosciences Holdings, Inc. (HRMY) Technical Analysis & Indicators
Harmony Biosciences Holdings, Inc. (HRMY) — Price $37.02 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ
Latest reported results:
Technical analysis of Harmony Biosciences Holdings, Inc. (HRMY): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc.